Pliva
Pliva is a pharmaceutical company based in Zagreb, Croatia. It is one of the largest pharmaceutical companies in Central Europe and the Balkans. Pliva is a subsidiary of the multinational pharmaceutical company, Teva Pharmaceutical Industries.
History[edit | edit source]
Pliva was founded in 1921, originally under the name Koprivnica. It was renamed to Pliva in 1930. The company has a long history of producing a wide range of pharmaceutical products, including prescription drugs, over-the-counter drugs, and generic drugs.
In 2008, Pliva was acquired by Teva Pharmaceutical Industries, a global pharmaceutical company based in Israel. This acquisition has allowed Pliva to expand its reach and influence in the global pharmaceutical market.
Products[edit | edit source]
Pliva produces a wide range of pharmaceutical products. These include prescription drugs for a variety of medical conditions, over-the-counter drugs for common ailments, and generic drugs that provide affordable alternatives to brand-name medications. Some of the key products produced by Pliva include azithromycin, a widely used antibiotic, and sumatriptan, a medication used to treat migraines.
Research and Development[edit | edit source]
Pliva has a strong focus on research and development. The company invests heavily in the development of new drugs and treatments, and works closely with healthcare professionals and researchers to ensure the safety and efficacy of its products. Pliva's research and development efforts have resulted in a number of significant breakthroughs in the pharmaceutical industry, including the development of the first generic version of the popular antidepressant, fluoxetine.
Impact[edit | edit source]
Pliva has had a significant impact on the pharmaceutical industry in Central Europe and the Balkans. The company's products are widely used in these regions, and its research and development efforts have contributed to the advancement of healthcare in these areas. Furthermore, Pliva's acquisition by Teva Pharmaceutical Industries has allowed the company to expand its influence on a global scale.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
